Genset researchers will use Celera’s integrated database products, bioinformatics systems, and other discovery tools in conducting their genomics research and will access Celera’s products through the web-based Celera Discovery System.
Andre Pernet, Genset’s president and CEO commented in a press release, The quantity and quality of the data in Celera’s databases should enable us to accelerate and reduce the costs of our genomics research. This will allow us to focus our time and resources on adding functional and medical information to genomics data. We believe the tools and experience we have developed over the past years have prepared us to fully exploit this data.
